Search Results - "Garcia‐Pagan, Juan C."

Refine Results
  1. 1

    Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial by Escorsell, Àngels, Pavel, Oana, Cárdenas, Andrés, Morillas, Rosa, Llop, Elba, Villanueva, Càndid, GarciaPagán, Juan C., Bosch, Jaime

    Published in Hepatology (Baltimore, Md.) (01-06-2016)
    “…Balloon tamponade is recommended only as a “bridge” to definitive therapy in patients with cirrhosis and massive or refractory esophageal variceal bleeding…”
    Get full text
    Journal Article
  2. 2

    Idiopathic noncirrhotic portal hypertension by Schouten, Jeoffrey N.L., GarciaPagan, Juan C., Valla, Dominique C., Janssen, Harry L.A.

    Published in Hepatology (Baltimore, Md.) (02-09-2011)
    “…Idiopathic noncirrhotic portal hypertension (INCPH) is characterized by an increased portal venous pressure gradient in the absence of a known cause of liver…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Acute variceal bleeding: risk stratification and management (including TIPS) by Hernández-Gea, Virginia, Berbel, Claudia, Baiges, Anna, García-Pagán, Juan C.

    Published in Hepatology international (01-02-2018)
    “…Acute variceal bleeding should be suspected in all patients with cirrhosis presenting with upper gastrointestinal bleeding. Vasoactive drugs and prophylactic…”
    Get full text
    Journal Article
  5. 5

    Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleeding: A Meta-analysis by Qi, Xingshun, Jia, Jia, Bai, Ming, Guo, Xiaozhong, Su, Chunping, García-Pagán, Juan C, Han, Guohong, Fan, Daiming

    Published in Journal of clinical gastroenterology (01-07-2015)
    “…BACKGROUND AND AIMS:Acute variceal bleeding is the most common lethal complication of liver cirrhosis. A meta-analysis was conducted to compare the outcomes of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Noninvasive Prediction of Clinically Significant Portal Hypertension and Esophageal Varices in Patients With Compensated Liver Cirrhosis by BERZIGOTTI, Annalisa, GILABERT, Rosa, ABRALDES, Juan G, NICOLAU, Carlos, BRU, Concepcion, BOSCH, Jaime, GARCIA-PAGAN, Juan C

    Published in The American journal of gastroenterology (01-05-2008)
    “…We aimed to develop a model based on noninvasive variables for the prediction of clinically significant portal hypertension (CSPH) and of esophageal varices…”
    Get full text
    Journal Article
  8. 8

    Pre-emptive TIPS for the treatment of bleeding from gastric fundal varices: Results of a randomised controlled trial by Escorsell, Angels, Garcia-Pagán, Juan C., Alvarado-Tapia, Edilmar, Aracil, Carles, Masnou, Helena, Villanueva, Càndid, Bosch, Jaume

    Published in JHEP reports (01-06-2023)
    “…Bleeding from gastric fundal varices (isolated gastric varices type 1/gastroesophageal varices type 2) represents a major problem because of a high incidence…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis by Reverter, Enric, Blasi, Annabel, Abraldes, Juan G., Martínez-Palli, Graciela, Seijo, Susana, Turon, Fanny, Berzigotti, Annalisa, Balust, Jaume, Bosch, Jaume, García-Pagán, Juan C.

    Published in Liver international (01-01-2014)
    “…Background & Aims Measurement of the hepatic venous pressure gradient (HVPG) offers valuable prognostic information in patients with cirrhosis. In specific…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Role of gap junctions modulating hepatic vascular tone in cirrhosis by Hernández-Guerra, Manuel, González-Méndez, Yanira, de Ganzo, Zaida A., Salido, Eduardo, García-Pagán, Juan C., Abrante, Beatriz, Malagón, Antonio M., Bosch, Jaime, Quintero, Enrique

    Published in Liver international (01-07-2014)
    “…Background & Aims Gap junctions are formed by connexins (Cx), a family of proteins that couple endothelial and smooth muscle cells in systemic vessels. In this…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis by Bellis, Lia, Berzigotti, Annalisa, Abraldes, Juan G., Moitinho, Eduardo, Garcı́a-Pagán, Juan C., Bosch, Jaime, Rodés, Juan

    Published in Hepatology (Baltimore, Md.) (01-02-2003)
    “…Postprandial hyperemia is associated with a significant increase in portal pressure in cirrhosis, which may contribute to progressive dilation and rupture of…”
    Get full text
    Journal Article
  19. 19

    Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome by HERNANDEZ-GUERRA, Manuel, LOPEZ, Eric, BELLOT, Pablo, PIERA, Carlos, TURNES, Juan, ABRALDES, Juan G, BOSCH, Jaime, GARCIA-PAGAN, Juan C

    Published in Hepatology (Baltimore, Md.) (2006)
    “…Budd-Chiari syndrome (BCS) causes postsinusoidal portal hypertension, which leads to complications similar to those observed in cirrhosis. However, no studies…”
    Get full text
    Journal Article
  20. 20

    Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension by HERNANDEZ-GUERRA, Manuel, GARCIA-PAGAN, Juan C, TURNES, Juan, BELLOT, Pablo, DEULOFEU, Ramon, ABRALDES, Juan G, BOSCH, Jaime

    Published in Hepatology (Baltimore, Md.) (01-03-2006)
    “…Patients with cirrhosis show intrahepatic endothelial dysfunction, characterized by an impaired flow-dependent vasorelaxation. This alteration is responsible…”
    Get full text
    Journal Article